The California Research Group publishes promising results for a universal peptide-based cancer vaccine



SANTA CLARA, California, 7. November 2018 / PRNewswire / – Team drs. The Rath Research Institute in California has developed a cancer vaccine
which reduces tumor growth. This peptide-based vaccine guides specific enzymes, called metalloproteinases (MMPs), which are responsible for tumor growth
Responsibility is the emergence of metastases and blood vessels in tumors (angiogenesis). Dr. The Rath research team showed that the tested mice were vaccinated with peptides specific
Sequences of MMP-2 and MMP-9, and then infected with cancerous melanoma cells, the mean reduction in tumor is approximately 76% compared to non-carcinogenic
Animals from the control group. It is remarkable that some vaccinated animals did not have any cancer at all.

The California research group is the result of a universal peptide-based cancer vaccine

The study was published in October 2018 in the online journal of cell medicine and natural health.


Source link